Avillion Life Sciences Email Format

Pharmaceutical ManufacturingEngland, United Kingdom11-50 Employees

Avillion Life Sciences is a United Kingdom–based drug development company that concentrates on late-stage clinical programs. It pursues a collaborative model designed to move therapeutic candidates toward regulatory approval in the EU and US and to shorten the time to market. The firm partners with other pharmaceutical developers to co-develop and advance late-phase candidates through the later stages of development. Located in London, England, the company maintains a small, specialized team. Operating in the pharmaceutical manufacturing sector, Avillion positions itself as a facilitator for companies seeking to progress late-stage assets toward approval in key markets. A notable development in 2022 was the expansion of its collaboration with AstraZeneca on PT027, reflecting continued engagement with major industry partners.

Sign up for free to view info

Company overview Employee directory